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Pseudomonas aeruginosa is an opportunistic pathogen that causes chronic infections in individuals suffering
from the genetic disorder cystic fibrosis. In P. aeruginosa, the transcriptional regulator AlgR controls a variety
of virulence factors, including alginate production, twitching motility, biofilm formation, quorum sensing, and
hydrogen cyanide (HCN) production. In this study, the regulation of HCN production was examined. Strains
lacking AlgR or the putative AlgR sensor AlgZ produced significantly less HCN than did a nonmucoid isogenic
parent. In contrast, algR and algZ mutants showed increased HCN production in an alginate-producing
(mucoid) background. HCN production was optimal in a 5% O2 environment. In addition, cyanide production
was elevated in bacteria grown on an agar surface compared to bacteria grown in planktonic culture. A
conserved AlgR phosphorylation site (aspartate at amino acid position 54), which is required for surface-
dependent twitching motility but not alginate production, was found to be critical for cyanide production.
Nuclease protection mapping of the hcnA promoter identified a new transcriptional start site required for HCN
production. A subset of clinical isolates that lack this start site produced small amounts of cyanide. Taken
together, these data show that the P. aeruginosa hcnA promoter contains three transcriptional start sites and
that HCN production is regulated by AlgZ and AlgR and is maximal under microaerobic conditions when the
organism is surface attached.
Pseudomonas aeruginosa is a gram-negative opportunistic
pathogen that can cause acute infections in patients suffering
from cancer (6), human immunodeficiency virus/AIDS (27,
51), and severe burns (9). P. aeruginosa can also cause chronic
infections in patients affected with the genetic disorder cystic
fibrosis (CF) (8, 31). Mutation of the gene that encodes the CF
transmembrane conductance regulator, a chloride ion channel
found in epithelial cells, results in a dehydrated layer of mucus
in the airways of the lungs. The impaired mucociliary clearance
entraps bacteria and allows for the establishment of a chronic
infection (65, 85). Pulmonary colonization by P. aeruginosa is
the leading cause of morbidity and mortality of CF patients (8).
During chronic CF infection, P. aeruginosa strains acquire
mutations that cause them to undergo a phenotypic switch
from a nonmucoid to a mucoid phenotype. The mucoid phe-
notype results from the production of copious amounts of the
capsular exopolysaccharide alginate (23). The presence of a
mucoid strain in the CF lung is associated with a worsening
clinical prognosis (22, 24). Production of alginate aids the
organism in the evasion of phagocytosis and in resistance to
killing by neutrophils and macrophages (11, 64, 74), quenching
of oxygen intermediates (46, 76), and antibiotic resistance (1).
Alginate biosynthesis is regulated by multiple factors (34, 69)
including the transcriptional regulator AlgR, a response regu-
lator belonging to the bacterial two-component signaling sys-
tem superfamily (21, 35). AlgR is required for virulence in an
acute septicemia model (48) and regulates a variety of other
virulence factors, including twitching motility (80, 81), hydro-
gen cyanide (HCN) production (13), and biofilm formation
and quorum sensing (58).
The effects of cyanide on various cell types have been ex-
tensively tested, and depending on cell type and level of oxi-
dative stress, cyanide causes either apoptosis or necrosis (66,
67). P. aeruginosa was one of the first bacteria shown to un-
dergo cyanogenesis (18). Growing evidence suggests that HCN
production may be an important virulence factor. The pres-
ence of cyanide in burn wounds was directly associated with P.
aeruginosa infections (33). More recently, the ability of P.
aeruginosa to paralyze and kill Caenorhabditis elegans in an in
vitro model was shown to be dependent on hcnC (30). HCN
production has also proven to be clinically relevant in the CF
lung as (i) P. aeruginosa CF isolates produced higher levels of
HCN than did laboratory strains (13), (ii) cyanide has been
detected in the sputum of P. aeruginosa-infected CF and bron-
chiectasis patients (12, 26, 40, 71), and (iii) detection of HCN
in sputum and bronchoalveolar lavage fluid directly correlated
with a worsening prognosis (12). The reported HCN concen-
trations in the sputum of infected patients ranged from 1.6 to
3.25 times the lethal blood concentration (71).
HCN is a secondary metabolite of P. aeruginosa produced
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from glycine in a poorly understood oxidative reaction cata-
lyzed by HCN synthase (15, 82). HCN is not produced by P.
aeruginosa under anaerobic conditions (15) but is expressed
under low oxygen tensions (14). Optimal production requires
the anaerobic regulator ANR and the quorum sensing regula-
tors LasR and RhlR, which bind the hcnA promoter at high
cell densities during late exponential growth (62). There are
two reported transcriptional start sites for hcnA in P. aerugi-
nosa (62) and one in Pseudomonas fluorescens (45). P. aerugi-
nosa T1 is regulated by the rhl and las quorum sensing systems,
while T2 relies on a synergistic effect of LasR, RhlR, and ANR.
GacA and RsmA function as posttranscriptional regulators of
HCN production through juxtaposition of the hcnA ribosomal
binding site and indirectly by positively and negatively regulat-
ing amounts of N-acylhomoserine, respectively (43, 61, 70).
Additionally, AlgR directly regulates HCN production in P.
aeruginosa through control of T1 and T2 of the hcnA promoter.
Moreover, AlgR has recently been shown to repress HCN
production in nonmucoid strains and to activate production in
mucoid strains, demonstrating AlgR’s ability to switch from a
repressor to an activator (13).
The purpose of this study was to examine the role of AlgZ,
the putative sensor for AlgR in P. aeruginosa HCN production.
Two independent research groups identified the open reading
frame (PA5262) that encodes AlgZ almost simultaneously (80,
89). The first group identified this gene while screening a
transposon library for mutants that lost twitching motility and
termed the gene fimS (80). The second group identified this
same open reading frame while examining alginate production
and called it AlgZ (89). The algZ or fimS gene is located
directly upstream of algR and shares homology with other
two-component sensors. PA3385 has also been referred to as
algZ in the literature (2–4, 86) but has since been renamed
amrZ (3). In addition to identifying a previously unreported
hcnA transcriptional start site, the present study expands the
role of AlgZ and AlgR by providing evidence that this putative
sensor/regulator pair control HCN production through a sur-
face attachment-specific mechanism that requires the con-
served AlgR aspartate at position 54. These data suggest that
AlgZ functions as a kinase in regulating HCN production in
P. aeruginosa.
MATERIALS AND METHODS
Bacterial strains, plasmids, and growth conditions. The strains and plasmids
used in this study are listed in Table 1. Escherichia coli was grown on Luria-
Bertani (LB) agar (Difco). P. aeruginosa was grown on Pseudomonas isolation
agar (PIA; Difco). Both were incubated at 37°C overnight. LB agar was supple-
mented with kanamycin (25 g/ml) or ampicillin (50 g/ml), and PIA was
supplemented with tetracycline (300 g/ml), streptomycin (10 g/ml), or genta-
micin (10 g/ml) for selection, plasmid maintenance, or genetic manipulation.
DNA manipulations. The oligonucleotides used in this study are listed in Table
2. The plasmid pZKO442, a derivative of pCVD442 (25), was used to create a
907-bp in-frame deletion of the algZ gene in multiple strains. The deletion
plasmid was constructed by a two-step crossover PCR (37) with oligonucleo-
tide primers algZkoXbaF, algZkoR2, algZkoF2, and algZkoSstR using the PAO1
chromosome as the template DNA. Oligonucleotides algZkoXbaF and algZko-
SstR were used to engineer XbaI and SstI restriction enzyme sites to the 5 and
3 ends of the final PCR product, respectively. The resulting 1,743-bp fragment
was cloned into pCVD442 using the restriction enzymes XbaI and SstI. The
plasmid pUCP18Z was used to complement the algZ deletion strains. To con-
struct this plasmid, a 2,326-bp fragment was amplified by PCR with oligonucle-
otides algZko1 and algZko4 to obtain the algZ open reading frame and promoter
region from the PAO1 chromosome. This fragment was cloned into pCR2.1
(Invitrogen) and subcloned into the XbaI and KpnI restriction sites of pUCP18.
DNA manipulations. In-frame deletions of algZ were created in laboratory and
clinical P. aeruginosa strains by introducing the algZ deletion plasmid (pZKO442
[algZ]) through triparental conjugation (42) and selection of carbenicillin-
sensitive and sucrose-resistant double recombinants using the helper plasmid
pRK2013 (28). Deletion of algZ was confirmed by PCR and Southern blotting
with a digoxigenin-labeled probe (Roche) using oligonucleotides algZko1 and
algZko4 (data not shown). Western blot analysis with a monoclonal anti-AlgR
antibody, 3H9, confirmed that there were no polar effects on AlgR expression in
algZ deletion strains. In-frame deletion of the algR gene was confirmed by PCR
with oligonucleotides ArgHF and HemCR and Western blot analysis with anti-
AlgR antibody (20). The PAO1 algR algZ::Tcr mutant was created by electro-
porating fragmented chromosomal DNA from PAO6886 (algZ::Tcr) into PSL317









PAO1 Wild type NM 38
PAZ-1 algZ NM This study
PAO6886 algZ::Tcr NM 89
PSL317 algR NM 48
PSL317Z algZ::Tcr algR NM This study
PAO568 mucA2 M 29
PDO300 mucA22 M 54
PAZ568 mucA2 algZ M This study
PAO6884 mucA2 algZ::Tcr M 89
PAR568 mucA2 algR NM 13
PAO6885 mucA2 algZ::Gmr algR::Tcr NM 89
TUMC92 Clinical isolate NM 13
TUMC92Z algZ NM This study
TUMC92R algR NM 13
FRD-1 mucA M 32
FRD-1Z mucA algZ M This study
FRD-1R mucA algR::Smr NM 50
WFPAPAO1 Wild type NM 50
WFPA8 algR(D54N) NM 50
WFPA13 algR(D85N) NM 50
WFPA16 algR(D54N D85N) NM 50
WFPA8A mucA algR(D54N) NM This study
WFPA13A mucA algR(D85N) M This study
WFPA16A mucA algR(D54N D85N) M This study
WFPA8Z mucA algR(D54N) NM This study
WFPA13Z mucA algR(D85N) M This study
WFPA16Z mucA algR(D54N D85N) M This study
WFPA8AZ mucA algZ algR(D54N) M This study
WFPA13AZ mucA algZ algR(D85N) M This study
WFPA16AZ mucA algZ algR(D54N D85N) M This study
PAO1 vfr vfr NM This study
PAK Hyperpiliated N 39
PAK mucA mucA22 M 87
PAK algR algR::Gmr NM 87
PAK mucA
algR
mucA22 algR::Gmr NM 87
PA14 Wild type NM 68
PA103 Wild type NM 47
19660 Clinical isolate NM 83
X13273 Clinical isolate NM 83
S54485 Clinical isolate NM 83
CF27 Clinical isolate M 83
PAK pscC pscC NM 84
PAK HCN KI pscC; PAO1 hcnA promoter NM This study
Plasmids
pCR2.1 TA cloning vector; Apr Kanr Invitrogen
pCVD442 Gene replacement vector; Tcr
sacB
26
pZKO442 algZ in-frame deletion vector; Apr This study
pUCP18 Expression vector; Tcr 78
pUCP18Z algZ expression vector for
complementation
This study
pRK2013 Helper plasmid for conjugation,
tra functions
28
pEXGmGW Gateway converted pEX18Gm 83
phcnAKI pEXGmGW with hcnA PAO1
promoter
This study
a M, mucoid; NM, nonmucoid.
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and selection of tetracycline-resistant recombinants, as described by Choi et al.
(17). Deletion of algR and insertional inactivation of algZ was confirmed by
Southern blot analysis using digoxigenin-labeled probes (Roche) created with
primers ArgHF and HemCR or algZko1 and algZko4, respectively (data not
shown).
The entire hcnA promoter region from PAO1 was amplified from genomic
DNA with primers PhcnA KI 5 and PhcnA KI 3 (Table 2). The resulting PCR
fragment (700 bp) was engineered with AttB1 and AttB2 sequences at the 5 and
3 ends, respectively, and cloned into pEXGmGW (84) via cloning to create the
hcnA knock-in (KI) vector phcnAKI. This 700-bp PAO1 hcnA promoter frag-
ment was introduced into an attenuated PAK strain (PAKpscC), which lacks a
functioning type III secretion system, as previously described (84). Positive hcnA
KI mutants were identified by PCR and confirmed by sequencing.
S1 nuclease protection assays. RNA for S1 nuclease protection assays was
isolated from PAO1, PSL317 (algR), and PAZ (algZ) grown in LB to station-
ary phase using CsCl as previously described (52). An S1 nuclease protection
assay was performed as previously described using 100 g of RNA with the
following modifications (51). The 519-bp region of the hcnA promoter ranging
from 495 to 24 (numbering relative to the translational start site) was cloned
into M13mp18. Single-stranded phage DNA was isolated and used as a template
for the uniformly labeled ([-32P]dCTP; NEN DuPont) single-stranded DNA
probe. Two probes were constructed using either of the oligonucleotides hcnAp-
rimetext and hcnAS1BglI. Probes constructed with hcnAprimetext were digested
with BglI, and probes constructed with hcnAS1BglI were cut with BglI. Digested
probes were purified on a 5% polyacrylamide gel. Total RNA (100 g) was
hybridized to each probe at 67°C for 1 h. Reactions were then digested with S1
nuclease for 30 min and then precipitated. S1 reaction mixtures were electro-
phoresed through an 8% acrylamide-urea gel adjacent to a sequencing ladder
generated using the same oligonucleotide as the probe.
HCN production assay of P. aeruginosa strains. HCN was measured using a
modification of the protocols described by Zlosnik and Williams (91) and Gal-
lagher and Manoil (30). Laboratory and clinical P. aeruginosa isolates were
grown on PIA plates aerobically for 16 h at 37°C. The plates were then inverted
and individually sealed with lids containing 1 ml of 4 M NaOH. The inverted
plates were then placed inside a trigas incubator under microaerobic conditions
(5% O2, 5% CO2, and 90% N2) at 30°C for 4 h. After a 4-hour incubation at 30°C
and after 20 h total, the NaOH/NaCN was collected and measured directly using
a cyanide micro-ion-selective electrode (Lazar Research Laboratories) con-
nected to an Accument Basic AB15 pH meter (Fisher Scientific) set to read mVs.
Values recorded from known concentrations of a KCN standard ranging from 1
 105 to 1 M were used to generate a line of regression on a semilog graph.
Unknown values were calculated using the slope and y intercept of this line. For
the time course, cells were incubated with the NaOH for 4 hours prior to the
collection time indicated. Bacterial cells were collected from the plates, total
protein was determined by the Bradford assay (Bio-Rad) as previously described
(13), and HCN production was reported as mol HCN/mg protein.
Pseudomonas isolation liquid medium (2% peptone, 0.14% MgCl2, 1% K2SO4,
0.0025% Irgasan) broth cultures were grown in a sidearm flask with an attached
enclosed chamber with shaking at 150 rpm under temperature and oxygen con-
ditions identical to those of the plate-grown cultures. Four hours prior to the
collection time point 1 ml of 4 M NaOH was added to the sidearm collection
chambers to act as a cyanide trap. The micro-ion-selective electrode was used to
measure the cyanide concentration in the NaOH/NaCN collected in the attached
chamber and broth directly, and the concentrations were added together to
obtain the total amount of cyanide produced in the broth culture. The cells were
harvested by centrifugation, and total protein was determined as described
above. Six biological replicates were performed for each strain. One-way analysis
of variance (ANOVA) and the Tukey-Kramer multiple test were used for sta-
tistical analysis.
Optimization of oxygen concentration for P. aeruginosa HCN production.
PAO1 was grown on PIA plates aerobically for 16 h at 37°C. The plates were then
inverted, individually sealed with lids containing 1 ml of 4 M NaOH, and incu-
bated for 4 additional hours at 30°C in a trigas incubator under various oxygen
conditions (1%, 3%, 5%, 7%, 10%, and 15% O2). The NaOH/NaCN and total
protein were collected and measured as described above.
RESULTS
P. aeruginosa HCN production is surface attachment spe-
cific. HCN is produced by P. aeruginosa during the transition
from logarithmic to stationary growth phase at low oxygen
tensions and high cell densities due to regulation of the hcnA
promoter by the synergistic effects of the anaerobic regulator
ANR and the quorum sensing regulators LasR and RhlR (14,
16, 62). Cyanide production is also under the control of the
transcriptional regulator AlgR (13). RhlA and RhlI have re-
cently been shown to be controlled by AlgR through an attach-
ment-specific mechanism (58). A recent report showed in-
creased cyanide production from P. aeruginosa grown in a
static glass bead biofilm system (72). In order to determine if
HCN production is increased during surface growth, HCN
production by PAO1 was measured following growth of cells in
broth and on agar media. Planktonic cultures of P. aeruginosa
PAO1 produced a maximal amount of 0.94 mol HCN/mg
protein during the transition from mid-log to stationary phase
(8 h) consistent with previous findings (14, 16) (Fig. 1A). Cul-
tures grown on agar plates produced various amounts of HCN
over the time course with an increase at 20 h to 1.5 mol
HCN/mg protein (Fig. 1B). These results show that surface-
grown P. aeruginosa in stationary phase produces more HCN
than do planktonically grown cells.
Optimal oxygen tension for P. aeruginosa HCN production.
HCN is produced at low oxygen tensions during planktonic
growth (14, 16), but the optimal oxygen concentration for sur-
face-attached cells is unknown. To determine the range of
oxygen concentrations that permit HCN production, P. aerugi-
nosa was grown at various oxygen levels and HCN production
TABLE 2. Oligonucleotides used in this study
Name Oligonucleotide sequence Gene Locationa
algZkoXbaF CCCTCTAGACCCAGCAACTGGCAGGTGATCTCG algZ 889 to 866 ()
algZkoR2 ACGCCTGTCGCGTGCCTTTCGACGCTTGAATCGGATAGGCATCGACAGAG algZ 8 to 17 ()
algZkoF2 CGTCGAAAGGCACGCGACAGGCGT algZ 925 to 948 ()
algZkoSstR CCCGAGCTCGAGGCCTTTCAGGTAGAGCTGGA algZ 1736 to 1758 ()
algZKO1F TGTCTTCCTGGTTGTCCTTGTTGTA algZ 1212 to 1188 ()
S1algRhindIII CCCAAGCTTCCAGAGGTTCGTCATCGACAATCAG algZ 1090 to 1114 ()
algZKO4R CGAGTGGCGATGCGGATT algZ 1950 to 1967 ()
hcnAprimetext GTGTTGACGACGTTCAAGAAGGTGCAT hcnA 495 to 24 ()
hcnAS1BglI GCAAAGCCGGCTCACCCGTGGAGG hcnA 3166 to 3137
PhcnA KI 5 TACAAAAAAGCAGGCTCCGCTTCCGACCGCCCCAGGCGGCTGA hcnA 1622 to 1600 ()
PhcnA KI 3 TACAAGAAAGCTGGGTCCGCAGTTTTTCCAGCATCCGGGTCTA hcnA 533 to 508 ()
ArgHF ATATATGAGCTCGGACCTGTCCGACCTGTTCC argH 482 to 426 ()
HemCR ATATATGAGCTCGGCTGGCGTAGGTGTTCGAG hemC 1197 to 1177 ()
a Location numbering is relative to the translational start site of gene. (), coding strand; (), antisense strand.
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was measured. PAO1 produced the maximum amount of HCN
in a 5% oxygen environment (Fig. 1C). Consistent with previ-
ous studies, HCN production was greatly reduced as oxygen
tensions neared anaerobic or aerobic conditions (14, 16).
Identification of previously unidentified hcnA transcrip-
tional start site. AlgR directly regulates HCN production in P.
aeruginosa by controlling expression of hcnA from the T1 and
T2 transcriptional start sites (13). The effects of algZ deletion
on the transcription of the hcnA promoter were examined
under microaerobic growth conditions by an S1 nuclease
protection assay. This assay showed that AlgZ, like AlgR, is
required for repression of hcnA transcription in a nonmu-
coid background (Fig. 2A). Interestingly, the assay also re-
vealed an additional transcriptional start site (designated
T3) upstream of the two previously identified sites (13, 62).
The intensity of this band of protection indicates that the
amount of transcript produced from the T3 site is equal to
or greater than that of the T1 and T2 transcripts. The T3
start site is a G residue located 221 bp from the transla-
tional initiation codon.
A naturally occurring deletion upstream of hcnA results in
low cyanide production. Previously, Wolfgang et al. identified
a region upstream of hcnA in PAO1 (termed the exoY deletion
region) that is absent in several other laboratory and clinical
strains (83). The hcnA T3 transcriptional start site and previ-
ously identified AlgR and Lux  binding sites are all within this
deleted region (Fig. 2B) (13, 62). Measurement of HCN pro-
duction on the laboratory strain PAK, which features this chro-
mosomal deletion, showed low levels of cyanide production
(	0.3 mol/mg protein) in comparison to PAO1 (	1.4
mol/mg protein) (Fig. 3A) when measured under microaero-
bic conditions. Mutations in PAK algR, mucA2, or both did not
affect the amount of cyanide produced by these isogenic strains
(Fig. 3A). Sequence analysis of the hcnA promoter region in
strains PA14 (HCN production 
 0.4 mol/mg protein) and
PA103 (HCN production 
 0.1 mol/g protein) revealed that
they did not contain the hcnA T3 promoter either (data not
shown). Insertion of the PAO1 hcnA promoter onto the PAK
chromosome by homologous recombination restored HCN
production to PAO1 wild-type levels in the PAK background
(Fig. 3A). Moreover, cyanide measurements of blood isolate
X13273, urinary tract infection isolate S54485, eye isolate
19660, and clinical isolate CF27, all previously shown to con-
tain the same deletion region (83), revealed that these strains
also produce very little HCN (Fig. 3B).
AlgZ activates and represses HCN production in P. aerugi-
nosa. Previous analysis of HCN production in P. aeruginosa
strains indicated that mucoid strains produce approximately
sevenfold more HCN than do their nonmucoid parental
strains. In-frame algR deletions in nonmucoid strains produced
	3-fold more HCN and 	1.5-fold less HCN in a mucoid
background, showing that AlgR switches from a repressor to
an activator of the hcnA promoter depending upon mucoid
status (13). Both AlgR and AlgZ are involved in alginate pro-
duction (19, 89) and required for twitching motility (5, 80, 81).
An S1 nuclease protection assay indicated that AlgZ also plays
a role in HCN regulation (Fig. 2A). Cyanide production levels
from in-frame algZ deletion and insertional algZ mutants in
both nonmucoid and mucoid backgrounds were measured un-
der microaerobic conditions on agar plates. Mutations in algR,
algZ, or both resulted in a 	3-fold increase in HCN production
in nonmucoid laboratory strains (Fig. 4A) compared to the
wild type. In mucoid laboratory strains, mutations in algR,
algZ, or both resulted in an 	3.5-fold decrease in HCN pro-
duction (Fig. 4B). In order to determine if the results observed
with laboratory strains and their isogenic mutants are consis-
tent with those for clinical isolates, HCN production was mea-
sured in mucoid and nonmucoid CF isolates and their isogenic
algR and algZ mutants. Consistent with the results for the
laboratory strains, mutations in algR or algZ resulted in an
	1.5-fold increase in HCN production in nonmucoid clinical
isolates (Table 3). In mucoid clinical isolates, mutations in algR
or algZ resulted in a decrease in HCN production (Table 3).
Additionally, complementation of the algZ mutant with the
wild-type allele restored HCN production to wild-type levels in
all strains (Fig. 4A and B). These results provide evidence that
AlgZ works through AlgR to regulate HCN production.
AlgZ and AlgR regulation of HCN production is surface
attachment specific. AlgZ and AlgR are both required for
fimbrial biogenesis (80, 81) and affect alginate production
(55, 56, 88). Both of these phenotypes are associated with
biofilm formation and surface colonization (60, 78). More-
over, AlgR control of the rhlI and rhlA promoters has re-
cently been shown to be surface attachment specific (58). In
order to determine if AlgZ and AlgR regulation of HCN
production was dependent on surface growth, cyanide assays
were performed on nonmucoid and mucoid strains both
grown in broth or on agar plates in stationary phase, 8 h for
FIG. 1. PAO1 HCN production in liquid and plate media and un-
der different oxygen tensions. (A) HCN production (solid squares and
solid line) by PAO1 in liquid Pseudomonas isolation broth and bacte-
rial CFU/ml (solid triangles and dotted line) over time. (B) HCN
production (solid squares and solid line) by PAO1 grown on PIA plates
and bacterial CFU/ml (solid triangles and dotted line) over time.
(C) HCN production under various oxygen tensions. Statistical signif-
icance was determined by one-way ANOVA and the Tukey-Kramer
test. ***, P  0.001.
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broth-grown strains and 20 h for plate-grown strains under
microaerobic conditions (see Materials and Methods) (Fig.
1A and B). In agreement with our previous data, strains
grown in broth produced approximately half (Table 4) the
amount of HCN observed when the same strains were grown
on plates (Fig. 4). In broth, neither algR nor algZ mutation
had an effect on HCN production in either background
(Table 4) whereas the same strains grown on agar plates
resulted in threefold changes in HCN production (Fig. 4).
Taken together, these results indicate that AlgZ/AlgR-
dependent cyanide production was regulated through a
surface-attachment-specific mechanism.
AlgR D54 is critical for HCN production. The aspartate at
position 54 of AlgR is highly conserved among two-compo-
nent regulators and is able to accept phosphate from E. coli
CheA in vitro (20, 50). An additional aspartate at position
85 is conserved in the AlgR homologues Staphylococcus
aureus LytR and E. coli YehT but is not capable of accepting
phosphorylation. AlgR D85 has been implicated in control-
ling the amount of pilin subunits exported (81). To deter-
mine the role of these conserved aspartates in HCN pro-
duction, site-directed AlgR mutants containing D54N,
D85N, or D54N D85N chromosomal alleles (81) were tested
for their ability to produce HCN under microaerophilic
conditions on PIA. These strains were made mucoid by
mutating the mucA gene, and HCN production was mea-
sured from all isolates. Though the parental strain of these
mutants, a PAO1 strain obtained from the Wozniak labora-
FIG. 2. The hcnA promoter is controlled by AlgZ and AlgR. (A) S1 nuclease protection assay of the hcnA promoter. Previously mapped
T1 and T2 transcriptional start sites (indicated by respective labels and arrows) of the nonmucoid strain PAO1 and algR and algZ
derivatives. The open triangle with the adjacent black line denotes the beginning of the common deletion region found upstream of the hcnA
promoter. (B) S1 nuclease protection assay identifying T3 transcriptional start site. The arrow indicates the band of protection indicating
the 1 start site. An asterisk denotes the first nucleotide in the antisense probe. (C) Sequence of the hcnA promoter region. The shaded
sequence denotes the exoY deletion region. Binding sites are underlined for AlgR (AlgR Binding Site), ANR (ANR Box), RhlR and LasR
(lux  and lux ), and ribosome (RBS). 1, HcnA translational start site; boldface nucleotides, hcnA open reading frame.
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tory, produced less cyanide than did our PAO1 strain, the
same trends for HCN production were observed for an algR
mutant and an algZ mutant as with our PAO1 strain (data
not shown). The AlgR D54N and AlgR D54N D85N mu-
tants produced increased HCN levels in nonmucoid strains
(	2-fold [Fig. 5A]) while producing lower levels in mucoid
(mucA::Tcr) strains (	3-fold [Fig. 5B]). Similar to the re-
sults obtained from assays of twitching motility (81) and
alginate production (50), the D85N mutant had no effect on
HCN production. Deletion of algZ resulted in the same
effects on HCN production as those found with the AlgR
D54N mutant (Fig. 5). These data show that repression of
HCN production in nonmucoid strains and activation in
mucoid strains are both dependent on AlgZ and AlgR D54.
Taken together, these data strongly suggest that phosphor-
ylation of AlgR D54 is required for HCN regulation and
that AlgZ is required for phosphorylation of AlgR. How-
ever, these data also indicate that phosphorylation of AlgR
is not the mechanism responsible for its ability to switch
from a repressor in nonmucoid P. aeruginosa to an activator
in mucoid isolates for HCN production.
DISCUSSION
This study shows that mutations in algZ or algR affect HCN
production in P. aeruginosa and that these effects are partially
due to the phosphorylation state of AlgR. In addition, results
shown here demonstrate that the hcnA promoter contains
three transcriptional start sites with the most upstream T3
promoter being required for maximal activity. The hcnA pro-
moter is controlled at transcriptional and posttranscriptional
levels by many different regulators including ANR (62, 90),
LasR and RhlR (62), GacA (7, 44, 61, 70), RsmA (10, 36, 44),
and AlgR (13, 49). Two hcnA promoters have been previously
reported for P. aeruginosa, termed T1 and T2 (62). T1 is reg-
ulated by quorum sensing alone, while T2 relies on a synergis-
tic effect of LasR, RhlR, and ANR (62). In P. fluorescens, there
are three RsmA/RsmE recognition elements that function as
posttranscriptional regulators of the hcnA promoter by directly
binding to the 5 leader region (44). The chromosome of P.
aeruginosa also contains rsmA, and deletion of this gene in-
creased HCN production, suggesting that RsmA may function
similarly in P. aeruginosa (63, 70). GacA also indirectly controls
HCN production by positively regulating the rhlI promoter and
hence amounts of N-butanoyl-homoserine-lactone (63, 70).
The effects of algZ and algR deletion on hcnA transcription
could be partially indirect, as AlgR represses rhlI transcription
FIG. 3. Strains with the exoY chromosomal deletion region up-
stream of hcnA produced decreased amounts of cyanide. (A) HCN
production from nonmucoid wild-type PAO1 and laboratory strains
with the exoY deletion region (PA14, PA103, and PAK), the PAK algR
deletion (PAK algR::Gm), the PAK mucA22 mutation, the PAK
mucA22 algR deletion, the PAK pscC deletion (PAK pscC), and the
PAK pscC deletion with the PAO1 hcnA promoter (PAK HCN KI).
(B) HCN produced from PAO1, CF isolate CF27, eye isolate 19660,
urinary tract infection isolate S54485, and blood isolate X13273. Sta-
tistical significance was determined by one-way ANOVA and the
Tukey-Kramer test. **, P  0.01, and ***, P  0.001, compared to the
isogenic parent.
FIG. 4. AlgZ and AlgR control HCN production. HCN production
for nonmucoid (A) and mucoid (B) algZ and algR mutants was mea-
sured as for Fig. 3. (A) PAO1, PSL317 (algR), PAZ (algZ),
PAO6886 (algZ::Tc), PAO6886 harboring pUCP18Z (algZ::Tc 
algZ), and PSL317Z (algR algZ::Tc). (B) PAO568, PAR568 (algR
mucA2), PAZ568 (algZ mucA2), PAO6884 (algZ::Tc mucA2),
PAO6884 harboring plasmid pUCP18Z (algZ::Tc mucA2  algZ), and
PAO6885 (algR::Gm algZ::Tc mucA2). Statistical significance was de-
termined as for Fig. 3.




(mean mol/g protein  SD)
TUMC92 Clinical 5.64  0.64
TUMC92R algR 9.30  0.32
TUMC92Z algZ 8.02  0.69
FRD-1 Clinical 7.60  0.62
FRD-1R algR 2.38  0.47
FRD-1Z algZ 2.89  0.08
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when P. aeruginosa is attached (58). However, AlgR has been
shown to bind directly to the hcnA promoter in vitro, indicating
that it controls HCN production directly (13). The most plau-
sible explanation is that AlgR is interacting with other regula-
tors (RhlR, ANR, or others) to control hcnA. Further studies
are under way to determine the effects of AlgR, ANR, RsmA,
LasR, and RhlR interactions on the hcnA promoter.
S1 nuclease protection assays (Fig. 2) established that there
is one additional transcriptional start site upstream of the two
previously reported. The hcnA-lacZ translational fusion used
in a previous study that contained the T3 transcriptional start
site showed higher -galactosidase activity than did those fu-
sions that lacked this promoter (62). The new start site is
located in the exoY deletion region and is found in several
laboratory and clinical strains (83). Results from Fig. 3 indicate
that T3 may be at least as important as T1 and T2, as the
absence of this 5 region of the hcnA promoter resulted in
extremely low levels of HCN production. These data suggest
that the T3 promoter is responsible for a considerable amount
of hcnA expression in P. aeruginosa. Interestingly, with the
exception of PAK and CF27, most of the strains examined with
this deletion region are exoU positive and exhibit increased
type III secretion activity compared to PAO1, suggesting that
only one of these virulence factors may be featured in a given
strain (83).
It has been proposed that AlgZ acts as the sensor to AlgR in
a two-component regulatory system (80, 89). The gene encod-
ing AlgZ is directly upstream of algR, and both proteins share
homology to two other sensor/regulator pairs, S. aureus lytS
and lytR and E. coli yehU and yehT. In fact, AlgR, LytR, and
AgrA compose a unique branch of the two-component system
family, called the LytTR family (59). In this study we provide
additional evidence that AlgZ acts as the AlgR sensor. Dele-
tion of algZ resulted in the same phenotype as did an algR
deletion and the site-directed algR(D54N) strain with respect
to HCN production, strongly indicating that AlgZ acts through
AlgR to control this promoter.
The AlgR response regulator responds to different environ-
mental conditions depending upon the promoter examined.
For instance, AlgR responds to nitrate concentrations on the
algD promoter (57) and to surface contact or perhaps lowered
oxygen tensions in control of the rhlI and rhlA promoters (58).
HCN is not produced by P. aeruginosa under aerobic or an-
aerobic conditions (15) but is expressed under low oxygen
tensions that range from 0.1 M to 180 M dissolved oxygen
in liquid medium (14). This broad range of HCN production
was not observed here (Fig. 1); however, the conditions used
in this study were differing concentrations of atmospheric ox-
ygen and not dissolved oxygen. The results presented here
show that HCN production was maximal at 5% (1.5 M O2)
and is within the range previously reported. Part of the oxygen
dependence can be explained by the requirement for the an-
aerobic regulator ANR for hcnA transcription (62, 90). How-
ever, it is not clear how or if AlgR and ANR interact directly.
The current data support a model where AlgR is repressing
hcnA and ANR is activating hcnA, in a nonmucoid back-
ground. In the mucoid background, the data indicate that there
may be some synergy between these two transcriptional regu-
lators to activate hcnA, as both are required for maximal hcnA
expression.
As with AlgZ and AlgR control of the rhlI and rhlA promot-
ers (58), changes in HCN production were not observed in
liquid cultures of P. aeruginosa in strains containing mutations
in algR or algZ. These results together suggest that AlgR may
respond to either a microaerobic environment or surface at-
tachment. Recently, Ryall et al. have shown that bacteria of the
Burkholderia cepacia complex are cyanogenic under biofilm
conditions (a glass bead system and agar plate) but not in
FIG. 5. AlgR D54 is critical for HCN. (A) HCN production was
measured from WFPAO1, WFPAO1 with chromosomal algR mutation
D54N (AlgR D54N), WFPAO1 with chromosomal algR mutation
D85N (AlgR D85N), WFPAO1 with double chromosomal algR muta-
tions D54N and D85N (AlgR D54N D85N), WFPAO1 containing
chromosomal algR mutation D54N and an algZ deletion (D54N
algZ), and WFPAO1 containing chromosomal mutations in algR
D54N and D85N and an algZ deletion (D54N D85N algZ). (B) HCN
production from mucoid derivatives (mucA::Tc) of the same site-di-
rected algR and algZ mutants as those in panel A. Statistical signifi-
cance was determined as described for Fig. 3.
TABLE 4. Effects of algR and algZ mutations in broth-grown
strains on HCN production
Strain Genotype HCN production(mean mol/g protein  SD)
PAO1 Wild type 0.63  0.05
PSL317 PAO1 algR 0.55  0.01
PAZ PAO1 algZ 0.55  0.01
PAO568 mucA2 0.55  0.01
PAR568 PAO568 algR 0.57  0.01
PAZ568 PAO568 algZ 0.63  0.01
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liquid cultures (73). The results shown in Fig. 1A are in agree-
ment with those studies. Cultures grown on agar have been
described as open-air biofilms (41) and share many character-
istics, including surface attachment, high cell densities, and
coordinated cellular behavioral patterns (41, 75). Type IV pili
could directly mediate either interaction and simultaneously
act as a sensor for attachment and have been shown to affect
gene transcription of lipC (53). Alternatively, surface growth
could have a nonspecific effect. For example, surface growth
could result in high local concentrations of signaling molecules
(N-acylhomoserine lactones) or alterations in the local avail-
able O2 concentration, all things known to affect HCN produc-
tion (14, 62, 63). In order to address this possibility, HCN was
measured in a pilA strain that resulted in a slightly lower but
not statistically significant amount of HCN compared to the
amount produced by PAO1 (data not shown). Further studies
are being performed to elucidate this potentially important
mechanism.
P. aeruginosa has been proposed to grow in a biofilm in the
CF lung, and this environment also contains the low oxygen
tension and high cell density required for HCN production (77,
85). A steep oxygen gradient is present within secondary bron-
chi, reported as more than 70 times lower than the partial
pressure of oxygen (pO2) found in the primary bronchi (85).
Recently, reports have shown that HCN is detectable in the
sputum and bronchoalveolar lavage fluid (12, 40, 71) of CF
patients and is associated with impaired lung function. These
reports are consistent with our previous data showing that 86%
of CF isolates produced HCN (13) and with the data of others
who have measured volatile compounds from CF sputum sam-
ples and detected HCN in vitro (12). Altogether, these data
indicate that HCN may be an important virulence determinant
for P. aeruginosa in CF.
Previous studies show that AlgZ and AlgR are both activa-
tors of twitching motility, with AlgZ acting in an AlgR-depen-
dent manner. It has also been shown that AlgZ is a repressor
of alginate production in the mucoid strain PAO568 (88), while
AlgR acts as an activator (19, 55, 56). The conserved AlgR
aspartate at position 54 does not play a role in alginate pro-
duction in P. aeruginosa (50); however, it is required for twitch-
ing motility (81). The different phenotypes observed in alginate
and twitching motility with respect to AlgR D54N suggest both
a phosphorylation-dependent and a phosphorylation-indepen-
dent mechanism for AlgR regulation. Analysis of HCN pro-
duction by P. aeruginosa strains demonstrated that AlgR
switches from a repressor to an activator of the hcnA promoter
depending upon mucoid status (13). This study demonstrates
that AlgR control of HCN production requires AlgR D54,
indicating that some regulation occurs through the phosphor-
ylation-dependent mechanism. In contrast, the AlgR switch
from repressor to activator is still observed in the AlgR D54N
site-directed mutants in comparisons of the nonmucoid to the
mucoid background. These data provide evidence that phos-
phorylation is not the mechanism by which AlgR switches from
a repressor to an activator in the mucoid background. Further-
more, these data suggest that AlgZ acts as a kinase in the
microaerobic environment necessary for HCN production.
Further investigation into the protein-protein interactions and
posttranslational modification of AlgR is required to explain
the repressor/activator switch.
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